Myelin lesions associated with lysosomal and peroxisomal disorders (Q37785556)

23 August 2017

title

Myelin lesions associated with lysosomal and peroxisomal disorders (English)

1 reference

23 August 2017

Phyllis L. Faust

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20819015

7 July 2024

Edward M. Kaye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20819015

7 July 2024

James M. Powers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20819015

7 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20819015

7 July 2024

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

http://www.future-drugs.com/doi/abs/10.1586/ern.10.127

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20819015

http://www.tandfonline.com/doi/pdf/10.1586/ern.10.127

7 July 2024

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

7 July 2024

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1449-1466

1 reference

23 August 2017

cites work

The lysosome turns fifty

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Autophagy in the Pathogenesis of Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Pathogenic cascades in lysosomal disease-Why so complex?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Lysosomal disorders: from storage to cellular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Neuronal ceroid lipofuscinoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Secondary lipid accumulation in lysosomal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Endocytosis conducts the cell signaling orchestra

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Salvage pathways in glycosphingolipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Characterization of new arylsulfatase A gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Mannose 6-phosphate receptor-dependent endocytosis of lysosomal enzymes is increased in sulfatide-storing kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Functional compartments of sulphatide metabolism in cultured living cells: evidence for the involvement of a novel sulphatide-degrading pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Krabbe disease: genetic aspects and progress toward therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Immune system irregularities in lysosomal storage disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Murine model of genetic demyelinating disease: the twitcher mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The function of sphingolipids in the nervous system: lessons learnt from mouse models of specific sphingolipid activator protein deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Biochemistry of mammalian peroxisomes revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Peroxisome biogenesis disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Peroxisomal disorders: the single peroxisomal enzyme deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Clinical and biochemical spectrum of D-bifunctional protein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Mutational spectrum of D-bifunctional protein deficiency and structure-based genotype-phenotype analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Peroxisomes, lipid metabolism and lipotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Peroxisomes and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The ether lipid-deficient mouse: tracking down plasmalogen functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Differential expression of peroxisomal matrix and membrane proteins during postnatal development of mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Adreno-leukodystrophy: oxidative stress of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Oligodendroglial impact on axonal function and survival - a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Peroxisomes, myelination, and axonal integrity in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Plasmalogens participate in very-long-chain fatty acid-induced pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Enzyme replacement for lysosomal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Site-specific analysis of N-linked oligosaccharides of recombinant lysosomal arylsulfatase A produced in different cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Metachromatic leukodystrophy: an overview of current and prospective treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Hematopoietic cell therapy for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The twitcher mouse: a model for Krabbe disease and for experimental therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

New prospects for the treatment of lysosomal storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Emerging trends in transplantation of inherited metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Nrf2, a multi-organ protector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

"Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Comparison of the behavior of neural stem cells in the brain of normal and twitcher mice after neonatal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Newborn screening of lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Newborn screening for adrenoleukodystrophy: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Newborn screening for Krabbe disease: the New York State model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of Krabbe disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Development and maturation of invariant NKT cells in the presence of lysosomal engulfment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Organelle interplay in peroxisomal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Cellular approaches for stimulating CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Insulin-like growth factor-1 and neurotrophin-3 gene therapy prevents motor decline in an X-linked adrenoleukodystrophy mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.127

Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy

21 January 2018

23

1 reference

Murine, canine and non-human primate models of Krabbe disease

7 July 2024

28

1 reference

Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis

7 July 2024

43

1 reference

Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy

7 July 2024

44

1 reference

Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation

7 July 2024

46

1 reference

The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria

7 July 2024

53

1 reference

Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin

7 July 2024

60

1 reference

Correction of Abnormal Cerebroside Sulfate Metabolism in Cultured Metachromatic Leukodystrophy Fibroblasts

7 July 2024

64

1 reference

Treatment of Late Infantile Metachromatic Leukodystrophy by Bone Marrow Transplantation

7 July 2024

67

1 reference

Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease

7 July 2024

83

1 reference

Bone marrow transplant in adrenoleukodystrophy

7 July 2024

90

1 reference

Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation

7 July 2024

91

1 reference

Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy

7 July 2024

93

1 reference

Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study

7 July 2024

95

1 reference

Therapy of X-linked adrenoleukodystrophy

7 July 2024

96

1 reference

Newborn screening for lysosomal storage disorders

7 July 2024

112

1 reference

7 July 2024

Identifiers

DOI

10.1586/ERN.10.127

1 reference

23 August 2017

1 reference